Operating Grant : Emerging COVID-19 Research Gaps and Priorities Funding Opportunity – LOI
Academic Unit: Inquire with your unit
Memorial Deadline: No RGCS review required for the LOI
External Deadline: Monday 15th, March 2021
This funding opportunity is part of Government of Canada’s continued response to address the health challenges of the COVID-19 pandemic. During the COVID-19 pandemic, domestic and international organizations (e.g. Public Health Agency of Canada, Health Canada, United States National Institutes of Health, and World Health Organization) have played critical roles in providing guidance, sharing data and coordinating the global response. The WHO R&D Blueprint has served as a guiding framework for international coordination, including the preparation of a coordinated Global Research Roadmap. The Government of Canada’s research investments have been informed by its participation in the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), an international organization composed of 29 members that coordinates closely with WHO. The Government of Canada has made an unprecedented investment in both the domestic and global response to COVID-19. This investment led to a mobilization of the research community to propose and carry out innovative and important research to address COVID-19 and related issues in Canada and internationally.
As the pandemic has evolved, so have the research needs of decision makers. There are important research gaps in Canada’s response that have become evident; gaps that need to be addressed rapidly and in a sustained manner to respond effectively to the pandemic. In order to achieve its goals, the Government of Canada will launch several funding opportunities under the “Emerging COVID-19 Research Gaps and Priorities” banner to address the identified research gaps in Canada. As priority gap areas are identified, additional funding opportunities will be launched. The purpose of this and upcoming funding opportunities is to provide rapid funding for projects which respond to identified gaps in COVID-19 research areas.
Gaps were identified through a broad engagement process which, either directly or by leveraging consultations undertaken by federal partners, sought input from Health Canada, the Public Health Agency of Canada, the Chief Science Advisor and related expert panels, and the National Advisory Council on Immunization as well as CIHR’s Institutes. CIHR will continue to engage its stakeholders in identifying emergent priorities in the coming months.
Research in priority areas is needed to effectively mitigate the rapid spread of COVID-19 and minimize its direct and indirect impacts on individuals and communities within and across jurisdictions in Canada and globally. Mitigation and recovery strategies require a coherent and integrated response from all Canadians, and especially from health care workers, researchers, public health authorities, industry, policymakers, decision makers at all levels, and the health system.
Additional information can be found at ResearchNet.